Aggressive thyroid cancer associated with toxic nodular goitre

European Journal of Endocrinology

Volumn 134, Issue 3, 1996, Pages 366-370

  Hayes, Frances J ^a   Sheahan, Kieran ^a   Heffernan, Andrew ^a   McKenna, T Joseph ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIMAZOLE; IODINE 131; LEVOTHYROXINE;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; THYROID CANCER; TOXIC GOITER;

EID: 0030000510     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340366     Document Type: Article

References (19)

1. Graham A. The thyroid gland in hyperthyroidism. Surg Clin North Am 1941;21:1331-63
2. Means JH. In: The thyroid and its diseases. Philadelphia: JB Lippincott, 1937:482
3. Olen E, Klinck GH. Hyperthyroidism and thyroid cancer. Arch Pathol 1966;81:531-5
4. Shapiro SJ, Friedman NB, Perzik SL, Catz B. Incidence of thyroid carcinoma in Graves' disease. Cancer 1970;26:1261-70
5. Farbota LM, Calandra DB, Lawrence AM, Paloyan E. Thyroid carcinoma in Graves' Disease. Surgery 1985;98:1148-52
6. Pacini F, Elisei R, Di Coscio GC, Anelli S, Macchia E, Concetti R, et al. Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest 1988;11:107-12
7. Belfiore A, Garofalo MR, Giuffrida D, Runello F, Filett S, Fiumara A, et al. Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab 1990;70:830-5
8. Southern Tumor Registry 11th Annual Report. Ireland: National Cancer Registry. University College Cork, 1990
9. Leeper RD. Thyroid cancer. Med Clin North Am 1985;69:1079-96
10. Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, et al. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer? J Clin Endocrinol Metab 1991;75:886-9
11. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am 1990;19:593-612
12. Filetti S, Belflore A, Amir SM, Daniels GH, Ippolito O, Vignerri R, et al. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 1988;318:753-8
13. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Wickham Survey. Clin Endocrinol 1977;7:481-93
14. Mazzaferri EL. Thyroid cancer and Graves'disease [editorial]. J Clin Endocrinol Metab 1990;70:826-9
15. McKenzie JM, Zakarija M, Sato A. Humoral immunity in Graves' disease. Clin Endocrinol Metab 1978;7:31-45
16. Clark OH, Caster BJ. Thyrotrophin receptors in normal and neoplastic human thyroid tissue. Surgery 1979;85:24-32
17. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 1974;38:976-98
18. Hoffman DA, McConahey WM, Diamond EL. Mortality in women treated for hyperthyroidism. Am J Epidemiol 1982;115:243-54
19. Holm LE, Dahlqvist I, Israelsson A, Lundell G. Malignant thyroid tumors after iodine 131 therapy. N Engl J Med 1980;303:188-91